Martin Vogelbaum

Founder at

Ajax Therapeutics, Inc.

62 year

73 connections

Health Technology

Finance

Consumer Services

Profile

Martin A. Vogelbaum is the founder of Gloucester Pharmaceuticals, Inc., Ajax Therapeutics, Inc. Current positions include Director & Managing Partner at Inning One Ventures, Partner at Rho Capital Partners, Inc. since 2005, and Non-Managing Member at RMV VI LLC.
Former roles include Director at Nuvelo, Inc. from 1997 to 2005, Director at Middlebrook Pharmaceuticals, Inc. from 2007 to 2010, Independent Director at Inotek Pharmaceuticals Corp.
from 2014 to 2016, Director at Mersana Therapeutics, Inc., AqueSys, Inc., SARcode Bioscience, Inc., Nora Therapeutics, Inc., and Medpace Research, Inc. from 2013 to 2014.
Served as Lead Independent Director at CARA Therapeutics, Inc. from 2015 to 2022, Vice President-Business Development at Celgene Corp.
from 2015 to 2017, General Partner at Oxford Bioscience Partners and Apple Tree Venture Management LLC, Associate at Memorial Sloan Kettering Cancer Center, and Advisor at The New York City Investment Fund Manager, Inc. Education includes undergraduate studies at The Trustees of Columbia University in The City of New York.

Martin Vogelbaum active positions

Companies	Position	Start
Rho Capital Partners, Inc. Rho Capital Partners, Inc. Investment ManagersFinance Rho Capital Partners invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors. It participates in seed, early and later stage transactions.	Private Equity Investor	2004-12-31
RMV VI LLC	Corporate Officer/Principal	-
Ajax Therapeutics, Inc. Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics	Founder	-

All active positions of Martin Vogelbaum

Former positions of Martin Vogelbaum

Companies	Position	End
CELGENE	Corporate Officer/Principal	2016-12-31
Inotek Pharmaceuticals Corp. Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye	Director/Board Member	2015-12-31
NEPHROGENEX INC	Director/Board Member	2014-04-30
Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients	Founder	2011-04-25
Middlebrook Pharmaceuticals, Inc. Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products	Director/Board Member	2010-03-21

See the detail of Martin Vogelbaum's experience

Training of Martin Vogelbaum

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Vogelbaum's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	19
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs	Health Technology
Oxford Bioscience Partners Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.	Finance
Nuvelo, Inc. Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies	Health Technology
Middlebrook Pharmaceuticals, Inc. Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products	Health Technology
Inotek Pharmaceuticals Corp. Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye	Health Technology
Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients	Health Technology
Mersana Therapeutics, Inc. Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications	Health Technology
CARA Therapeutics, Inc. CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed	Health Technology
AqueSys, Inc. AqueSys, Inc. Medical SpecialtiesHealth Technology Develops surgical products for surgeons	Health Technology
SARcode Bioscience, Inc. SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rho Capital Partners, Inc. Rho Capital Partners, Inc. Investment ManagersFinance Rho Capital Partners invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors. It participates in seed, early and later stage transactions.	Finance
Medpace Research, Inc. Medpace Research, Inc. Medical DistributorsDistribution Services Develops drugs and novel therapies for kidney diseases	Distribution Services
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital	Health Services
The New York City Investment Fund Manager, Inc. The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest.	Finance
Apple Tree Venture Management Llc//vc Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements.	Finance
Nora Therapeutics, Inc. Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages	Health Technology
RMV VI LLC
Ajax Therapeutics, Inc. Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics	Commercial Services